1. Home
  2. RRGB vs ACET Comparison

RRGB vs ACET Comparison

Compare RRGB & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RRGB

Red Robin Gourmet Burgers Inc.

HOLD

Current Price

$5.86

Market Cap

84.4M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.81

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRGB
ACET
Founded
1969
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.4M
77.3M
IPO Year
2002
2017

Fundamental Metrics

Financial Performance
Metric
RRGB
ACET
Price
$5.86
$7.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.00
$48.33
AVG Volume (30 Days)
475.6K
91.3K
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
73.43
N/A
EPS
N/A
N/A
Revenue
$1,315,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$0.46
52 Week High
$7.52
$9.47

Technical Indicators

Market Signals
Indicator
RRGB
ACET
Relative Strength Index (RSI) 73.25 48.77
Support Level $3.94 $7.70
Resistance Level $7.52 $8.68
Average True Range (ATR) 0.40 0.54
MACD 0.07 -0.03
Stochastic Oscillator 92.07 31.79

Price Performance

Historical Comparison
RRGB
ACET

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: